Anti-Obesity Biologics

Product description

The present Competitive Intelligence Report about new developments in the pipeline of biologics for treatment of obesity provides a competitor evaluation in the field of R&D projects from preclinical stages up to advanced clinical development of anti-obesity biologics as of March 2008.

The report includes a compilation of current active projects in research and development of peptides and oligonucleotides or antisense for the treatment of obesity. The pipeline includes drug delivery approaches for non-invasive administration. Among the competitors are peptide companies and companies offering novel drug delivery approaches.

Competitor projects are listed in a tabular format providing Information on:

Information is provided on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.